In 2016, 6 units were placed in the NHS, Royal Manchester children’s Hospital to reduce infection rates, both and sporadic incidences of CRE/ VRE infections.
This UV technology was independently tested by the NHS, and has and continues to prove itself at the RMCH.
“Our number one goal is to keep our patients safe, not only through the advanced care we provide, but also through the environment in which we provide that care,” said Julie Jolly, Matron – Service Improvement, Enhanced Recovery and Care Co-Ordination, and V2A Programme Lead (Children’s), for Royal Manchester Children’s Hospital.
“We are extremely pleased with the efficacy and impact of Surfacide’s Helios system in protecting our patients from the bacteria and viruses that can cause HAIs.”
RMCH conducted an independent pilot study using the UV-C Disinfection System in the hospital’s Oncology/Haematology Unit. The eight-month independent study compared standard cleaning protocols alone to those including Surfacide Helios UV-C Disinfection. The result was an 83.7% decrease in contaminated sites and a 43% decrease in HCAIs when the Helios system was introduced into the patient environment along with standard cleaning procedures.
The Helios system was effective at reducing and eliminating a variety of drug-resistant microorganisms and has been shown to eradicate multi-drug resistant organisms, including C. Diff, MRSA, VRE, CRE and Acinetobacter.
The Helios system introduces three UV-C energy emitting towers in the patient environment versus other systems that only use one. The triple emitter approach decreases the distance to contaminated surfaces thereby reducing disinfection time and improving overall efficacy. In addition, the system is highly effective at covering all areas of the room, including the bathroom and other hard-to-reach areas. Finally, it reduces the amount of time to clean a room since the emitters do not need to be moved during the cleaning process.
The 10-20-minute Helios disinfection cycle is performed in an unoccupied room after an environmental services cleaning professional has manually cleaned the area and wiped down surfaces. The system uses an automatic laser mapping feature to measure the room and detect potential areas of contamination. These measurements are then incorporated into an algorithm to determine an optimal time to complete the disinfection process
I am married with two kids, Alex and Daniel and live in Dublin Ireland. I am a qualified microbiologist with 25 years’ experience in the food, beverage, diary and pharmaceutical industries.
I Qualified from Sligo Institute of science in 1989, and for the last 25 years, have worked with various blue chip food companies within the quality departments. I have built up extensive experience in various start-up operations for companies diverse as HJ Heinz Russia, Idaho, Guinness, Sealed air and Johnson controls.
In 2017, after 15 years in sales, I decided to launch Hytech.ie. I saw a niche in the market, for a company, which offered a single platform in Ireland, to test new disinfection technologies under one brand, Hytech.ie.
Walter joins the Hytech family after a successful 38-year Nursing career in the NHS. Born and bred in the northwest of England with roots in Rochdale, nursing has taken him to Cambridge, South Manchester, North Manchester and latterly the Royal Manchester Children’s Hospital (RMCH).
For the last 10 years as Lead Nurse for Quality and Patient Experience, Walter has had a key role in leading on Infection Prevention and Control strategies and clinical practice. Following preliminary trials, Walter successfully implemented UV-C disinfection with Surfacide across RMCH with positive outcomes of reduced HCAI rates and improved patient experience.
Walter is delighted to join the team at Hytech and to work with clients enabling then to get the best outcomes from UV disinfection technologies to improve patient safety and patient experience across all healthcare settings.
BSc (Hons) Child Health – Specialist Practitioner
Henrik Lasthein is Hytech affiliate for Scandinavia for this technology. He has worked in the Health care sector in Scandinavia for over 25 years. He began in 3M as a sales representative and stayed with 3M for 15 years, heading businesses as Cardiovascular, orthopedics, critical care as well as sterilisation for 3m as a Scandinavian sales and marketing manager.
After a short stay for 2 years as Scandinavian manager for Terumo, Henrik founded his own Company Hemax and build a Company within the Health care sector. He sold Hemax after 10 succesful years to a Swedish Company Medcore and stayed on for 2 years as their CEO in Denmark.
After this Henrik managed 2 other startups and has been on one board for a orthopedic Company. He is today managing and owner of Hemedic which excells in sales to the Scandinavian Health care area.
Mohammed Sami Abdulfattah
Business Development Director Middle East
Mohammed is a Biomedical Engineer with MBA degree and has worked in healthcare industry for over 10 years. He has worked for medical suppliers in UAE, KSA and Kuwait then for the last 4 years as a Regional Director for Middle East for Venus Concept (Canadian Medical Equipment and Aesthetic laser Public company).
During his work for Venus Concept, he was responsible for the successful launching of several products including NeoGraft hair restoration Robots in 12 different countries. Neograft, Venus Concept and Solta Medical awarded him with certifications as a clinical and sales trainer for several Laser and RF technologies in Aesthetics and Medical field and Mohammed was responsible for the training of clinical trainers and medical staff in each country on their products.
The Hytech Vision
We offer not only expert opinions on new technology in this sector, but also access to trialing the technology, and unique for a single platform provider, offer full validation for the efficacy of the technology in YOUR environment, be that Hospital, Clinic, EMS services or Processed food sector.
My personal belief, is no one technology can offer full reduction or control in HAI’s, and therefore we offer a referral / peer review on with the latest technology companies to offer disinfection within the medical sector. Hytech commits to evolve over the coming years, reaching out to the industry, engaging with new technology manufacturers around the world.
Our Goal to create a presence in the Island of Ireland for their products, and provide ‘on the ground support’ to take that initial meeting with the customer, to a final trial in a medical environment along with full turn key micro analysis of results. Hytech Ireland was named as finalist, by the HIH 2019, for www.surfacide.com UV technology. Our key goal is to trial this technology now in Ireland in one of the smaller Children’s Hospitals, with the view to placing this product for operational use at the New national children’s Hospital Ireland in 2019/2020. A World class Hospital for a World class technology. Hytech Irelands journey continues.